Fertility Awareness Biomarkers

Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1

Leiva R, McNamara-Kilian M, Niezgoda H, Ecochard R, Bouchard T

Published May 27, 2019 BMJ Open, 9(5), e028496
DOI 10.1136/bmjopen-2018-028496 PMID 31133596 PMC PMC6538017

RRM Academy Synopsis

Home PDG urine test showed 100% specificity in a 22-cycle pilot

A pilot cohort study followed 22 women in Ottawa for one cycle each. The home PDG urine test gave no positive result before ovulation in 22 cycles (100% specificity). Sensitivity was 85% to 87%, depending on whether LH or mucus timing was used. Half the women found the results easy to read.

About 5 in 10 women found the home PDG test results easy to determine
About 5 in 10 women found the home PDG test results easy to determine. Source: Leiva R et al., 2019, PMID 31133596.
Study at a glance, pilot cohort study of 22 women: Home PDG urine test gave no positive result before ovulation in 22 cycles
Study at a glance, pilot cohort study of 22 women: Home PDG urine test gave no positive result before ovulation in 22 cycles. Source: Leiva R et al., 2019, PMID 31133596.

Key Findings

  • Specificity was 100% in 22 cycles. Serum progesterone showed all 22 cycles were ovulatory, and no PDG test was positive before ovulation.
  • Three straight positive PDG tests confirmed ovulation in 17 of 20 cycles (85%) after a positive LH test, and in 14 of 16 (87%) after peak-fertility mucus.
  • With a single positive PDG test, specificity stayed at 100%. Sensitivity rose to 95% in the LH arm and stayed at 87% in the mucus arm.
  • Of 22 participants, 11 (50%) agreed the results were easy to determine, and 11 described a faint remaining line.
  • Two of 22 cycles (9%) had no positive LH test, and 6 of 22 (27%) had no peak-fertility mucus day.

Interpretation

This cohort study followed 22 women in Ottawa for one cycle each, with ovulation confirmed by serum progesterone. All 22 cycles were ovulatory, and the home PDG test correctly withheld a positive result before ovulation in every one. The authors note that the single-test result is a hypothesis for a larger trial to test directly. The findings support a larger study of this home confirmation approach.

RRM Context

Fertility awareness methods and ovulation kits anticipate ovulation. The authors write that confirming it has needed a lab blood test or repeated vaginal ultrasound. Both require clinic visits. Restorative reproductive medicine treats the ovulatory cycle as a vital sign, and a home confirmation tool addresses a gap in charting.

Abstract

Rationale

Ovulation confirmation is a fundamental component of the evaluation of infertility.

Purpose

To inform the design of a larger clinical trial to determine the effectiveness of a new home-based pregnanediol glucuronide (PDG) urine test to confirm ovulation when compared with the standard of serum progesterone.

Methods

In this observational prospective cohort study (single group assignment) in an urban setting (stage 1), a convenience sample of 25 women (aged 18-42 years) collected daily first morning urine for luteinisinghormone (LH), PDG and kept a daily record of their cervical mucus for one menstrual cycle. Serum progesterone levels were measured to confirm ovulation. Sensitivity and specificity were used as the main outcome measures. Estimation of number of ultrasound (US)-monitored cycles needed for a future study was done using an exact binomial CI approach.

Results

Recruitment over 3 months was achieved (n=28) primarily via natural fertility regulation social groups. With an attrition rate of 22%, specificity of the test was 100% for confirming ovulation. Sensitivity varied depending on whether a peak-fertility mucus day or a positive LH test was observed during the cycle (85%-88%). Fifty per cent of participants found the test results easy to determine. A total of 73 US-monitored cycles would be needed to offer a narrow CI between 95% and 100%.

Conclusion

This is first study to clinically evaluate this test when used as adjunct to the fertility awareness methods. While this pilot study was not powered to validate or test efficacy, it helped to provide information on power, recruitment and retention, acceptability of the procedures and ease of its use by the participants. Given this test had a preliminary result of 100% specificity, further research with a larger clinical trial (stage 2) is recommended to both improve this technology and incorporate additional approaches to confirm ovulation.

Trial Registration

NCT03230084.

Topics

By this author

Related research

Fertility Awareness › Biomarkers › Urinary Hormone Monitoring · Diagnostics › Hormone Testing › Urinary Metabolites
Rene Leiva, Marie McNamara-Kilian, Helen Niezgoda, René Ecochard, Thomas Bouchard
R Leiva, M McNamara-Kilian, H Niezgoda, R Ecochard, Tom Bouchard, T Bouchard
PMID 31133596 31133596 DOI 10.1136/bmjopen-2018-028496 10.1136/bmjopen-2018-028496 Leiva et al. 2019, Leiva 2019